Monopar Therapeutics Competitors and Similar CompaniesClear all
Monopar Therapeutics's competitors and similar companies include Innate Pharma.
 Monopar Therapeutics Monopar Therapeutics is a biopharmaceutical company focused on developing innovative drugs and drug combinations to improve clinical outcomes for cancer patients. |  Innate Pharma Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. | |
Founding Date | Founding Date 2014 | Founding Date 1999 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Wilmette, US HQ | Locations Marseille, FR HQ Rockville, US |
Employees | Employees 4 | Employees 181 |
Valuation ($) | Valuation ($) 57.1 m | Valuation ($) 148.6 m |
Financial | ||
Net income | Net income ($13.6m) (FY, 2025) | Net income (€49.2m) (FY, 2025) |
Operating ⚠ | ||
Phase I Trials Products | Phase I Trials Products 1 (Sep, 2019) | Phase I Trials Products 3 (Q2, 2019) |
Phase II Trials Products | Phase II Trials Products 1 (Sep, 2019) | Phase II Trials Products 5 (Q2, 2019) |
Pre-Clinical Phase Products | Pre-Clinical Phase Products 1 (FY, 2018) | Pre-Clinical Phase Products 7 (Q2, 2019) |
Funding | ||
Total funding raised | Total funding raised $ 2.1m | Total funding raised $ 94.1m |
For sources of this data, please see the company profile
View Company Profiles
Innate Pharma
HQ
Marseille, FR
Employees
181
Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients.
View company